• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THE SPECTRANETICS CORPORATION STELLAREX 014; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THE SPECTRANETICS CORPORATION STELLAREX 014; DCB PTA CATHETER Back to Search Results
Model Number AA14SX025150150
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Cardiac Arrest (1762)
Event Date 11/24/2020
Event Type  Death  
Manufacturer Narrative
The patient's date of birth, ethnicity, and race are unknown.This information was not available from the facility.Foreign- netherlands/ study name: btk pm- patient id #(b)(6).Pma number is not applicable.The device is a commercial product with a ce mark that was used as part of a clinical study.During the index procedure, the product worked as intended and the device was discarded, thus no product evaluation was required.Although the cause of death is unrelated to the study device, death is listed in the ifu as a potential complications/ adverse events.Submission of this report does not, in itself, represent a conclusion by the manufacturer and/or authorized representative or the national competent authority that the content of this report is complete or accurate, that the medical device(s) listed failed in any manner and/or that the medical device(s) caused or contributed to an alleged death or deterioration in the state of the health of any person.
 
Event Description
It was reported through a clinical study that during the index procedure on (b)(6) 2020, two stellarex catheters (3011416935-2023-00002) were used to treat the target lesion of the left, tibioperoneal trunk, proximal peroneal, and distal posterior tibial artery.Approximately 23 months post index procedure, it was reported that the patient expired due to cardiac arrest on (b)(6) 2022.The physician indicated this is not related to the study device or procedure.This adverse event is being submitted because the patient expired due to cardiac arrest.This is being reported as a follow-up to the clinical study.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 014
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
THE SPECTRANETICS CORPORATION
6655 wedgwood road north
suite 105
maple grove MN 55311
Manufacturer (Section G)
SPECTRANETICS
6655 wedgwood road north
suite 105
maple grove MN 55311
Manufacturer Contact
ana tan
6655 wedgwood road north
suite 105
maple grove, MN 55311
510673-223
MDR Report Key16309010
MDR Text Key308910936
Report Number3011416935-2023-00001
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Reporter Country CodeNL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study
Reporter Occupation Physician
Type of Report Initial
Report Date 02/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/23/2022
Device Model NumberAA14SX025150150
Device Catalogue NumberAA14SX025150150
Device Lot NumberF8E20C20A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/23/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age85 YR
Patient SexMale
Patient Weight85 KG
-
-